2020台灣生技月 Bio Taiwan 生物科技大展

2020 台灣生技月 南港展覽館

講師

Pharmasaga Pharmaceutical Inc.

Biomedical EcoSystem development office in Taiwan, BEST

July 24th (Fri) 19:30 - 21:00 Entrepreneur Pitch 3

Pharmasaga Pharmaceutical Inc.

Company Info

Name /Pharmasaga Pharmaceutical Inc.

Address /A443, No. 99, Lane 130, Sec. 1, Academia Road, Nankang, Taipei, 115, Taiwan

Website /www.facebook.com/Pharmasaga-2383593451699976/

Presenter

Name /Tab, T. Y. Chen

Title /Chief Operating Officer

Email /taogc@gate.sinica.edu.tw

Telephone /(Work) 02-77505563

Fax /02-27822245

Mobile /0937-457634

Company Type

Pharmaceutical

About the Company

Current pre-money valuation is calculated NT$100M. Upon execution of Trust-U project, the post-money valuation is expected to hit NT$220M. We are looking to raise NTD 120M Pre-A round to cover IND application and phase I clinical trials.

Brief Description of main products or services

We discover a chaperone protein, PX, which is specifically expressed in β cells. PX protein is a target of diagnosis and therapy against T2D. Using molecular docking, chemical modification and lead optimization, PS1 is developed as a small-molecule drug candidate. We have proved that PS1 suppresses β cell dysfunction and loss via reduction of high glucose-mediated reactive oxygen species (ROS). Furthermore, PS1 alone and in combination can treat and reverse T2D.

Contact Person

Name /Tab, T. Y. Chen

Email /taogc@gate.sinica.edu.tw

Phone /02-77505563